Metagen Therapeutics, Inc.
brings innovative medicine and pharmaceuticals to life
with cutting-edge microbiome science
News
Pipeline/Platform
Fecal Microbiota Transplantation
Microbiome Drug Discovery
Founders
Chief Executive Officer
Taku Nakahara Ph.D., MBA
Chief Medical Officer
Dai Ishikawa MD, Ph.D.
Associate Professor
Dept. of Gastroenterology,
Fac. of Medicine,
Juntendo University
Chief Medical Officer
Shinji Fukuda MD, Ph.D.
Project Professor
Institute for Advanced Biosciences,
Keio University
Chief Technology Officer
Takuji Yamada Ph.D.
Associate Professor
School of Life Science and Technology,
Tokyo Institute of Technology
Recruit
No open positions available
腸内細菌療法
メタジェンセラピューティクスはCMO石川が順天堂大学で研究してきた腸内細菌療法の普及を目指します。
Partners
Company
Metagen Therapeutics, Inc. (MGTx)
June 2021
Drug discovery and medical business using microbiome science
President & CEO Taku Nakahara
Director, CSO Shinji Fukuda
Director, CTO Takuji Yamada
Director, CMO Dai Ishikawa
246-2 Mizukami, Kakuganji, Tsuruoka-city, Yamagata 997-0052 Japan
Toranomon Hills Business Tower 15F
1-17-1 Toranomon, Minato-ku, Tokyo 105-6324 Japan